In this paper, the authors pooled all consecutive patients hospitalised with laboratory-confirmed COVID-19 and acute ischaemic stroke across 28 sites from 16 countries.

In this paper, the authors report a case of a previously healthy 58-year-old man who acutely developed hyposmia, generalised myoclonus, fluctuating and transient changes in level of consciousness, opsoclonus and an asymmetric hypokinetic-rigid syndrome with ocular abnormalities following severe SARS-CoV-2 infection.

In this review recently published in JAMA, the authors summarise the current evidence regarding the pathophysiology, transmission, diagnosis, and management of COVID-19.

In this multicentre retrospective observational study, the authors analysed the impact of the COVID-19 pandemic on hospital stroke admissions and in-hospital mortality in tertiary referral hospitals in north-west Spain.

In this paper recently published in the official journal of the Hungarian Society of Neurologists, the authors discuss neurological signs and symptoms in COVID-19 patients; the effects of COVID-19 on services for other acute diseases; and changes in the care for patients with chronic neurological disorders.

In this review prepared by the Turkish Neurological Society COVID- 19 Committee, and recently published in the Turkish Journal of Neurology, the authors discuss multiple neurological aspects relating to COVID-19.

The aim of this retrospective, observational cohort study, published in Lancet Rheumatology, was to assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and death in patients with severe COVID-19 pneumonia who received standard of care treatment.

The objective of this retrospective multicentre cohort study was to investigate new-onset neurological impairment associated with COVID-19.

The objective of this cross-sectional observational study was to estimate the incidence and fatality of COVID-19 and identify potential risk factors to fatality in patients with active epilepsy.

The objective of this study was to report outcomes on patients with multiple sclerosis (MS) and related disorders with COVID-19 illness. From March 16 to April 30, 2020, patients with MS or related disorders at NYU Langone MS Comprehensive Care Center were identified with either laboratory-confirmed or suspected COVID-19.

In this retrospective multicentre study, recently published in Neurology, the authors describe neuroimaging findings and report the epidemiological and clinical characteristics of COVID-19 patients with neurological manifestations.

In this prospective survey‐based data collection and telemedicine follow‐up study, recently published in the European Journal of Neurology, the authors enrolled 751 patients with COVID-19 with the aim to investigate the patterns of olfactory recovery after COVID-19 infection

The objective of this retrospective cohort study, recently published in the European Journal of Neurology, was to assess the neurological manifestations in a series of consecutive SARS‐CoV‐2 positive patients, comparing their frequency with a population hospitalised in the same period for influenza/respiratory symptoms, found not to be related to SARS‐CoV‐2.

In this article recently published in Science, the authors performed an integrated immune analysis on a cohort of 50 COVID-19 patients with various disease severity.

In this nice review recently published in Lancet Neurology, the authors summarised the evidence for COVID-19 putative disease mechanisms, and suggested a framework for investigating patients with suspected COVID-19-associated neurological disease to support clinico-epidemiological, disease mechanistic, and treatment studies.